期刊文献+

氯沙坦对兔腹主动脉内皮损伤后过氧化物酶体增殖物激活受体-γ与纤溶酶原激活物抑制因子-1表达的影响 被引量:1

Effects of losartan on expression of peroxisome proliferators-activated receptor-γ and plasminogen activator inhibitor-1 after endothelia injury of abdominal artery in rabbits
下载PDF
导出
摘要 目的:观察氯沙坦对兔血管内膜损伤后过氧化物酶体增殖物激活受体-γ(PPARγ)及纤溶酶原激活物抑制因子-1(PAI-1)表达的影响,探讨氯沙坦预防动脉粥样硬化的可能机制和作用。方法:雄性新西兰大白兔24只,随机分为3组:普通饲料喂养组(G1组)、高脂饮食喂饲+动脉内皮损伤组(G2组)及高脂饮食喂饲+动脉内皮损伤+氯沙坦治疗组(G3组)。G2、G3组持续给予胆固醇喂养2周后行腹主动脉内膜剥脱术,G3组内膜剥脱术后第1天开始口服氯沙坦10 mg/kg。3组均于6周后取兔腹主动脉行病理形态学观察和免疫组织化学分析PPARγ和PAI-1蛋白表达,RT-PCR方法检测PPARγ和PAI-1 mRNA的表达。结果:高胆固醇喂养6周后,3组之间内膜厚度(IT)、内膜厚度与中膜厚度比(IT/MT)、内膜面积(IA)、内膜面积与中膜面积比(IA/MA)比较,差异均有统计学意义(F分别为48.700、69.100、133.200和97.500,P均<0.001)。3组之间PPARγ和PAI-1蛋白阳性表达率比较,差异均有统计学意义(F分别为13.800、26.500、9.200和17.400,P均<0.05)。结论:氯沙坦可抑制血管损伤后的内膜增生并改善血管重构,其机制可能与调节PPARγ,从而影响PAI-1水平,改善动脉粥样硬化有关。 Aim : To observe the effects of angiotensin type 1 receptor antagonist losartan on the expression of peroxi- some proliferators-activated reeeptor-γ (PPARγ) and plasminogen activator inhibitor-1 (PAI-1) after balloon injury in rab- bits,and to explore the possible mechanism of losartan in preventing atherosclerosis. Methods: A total of twenty-four male rabbits were randomly divided into three groups : ordinary feeding rabbits ( G1 ) ,cholesterol feeding + abdominal artery inju- ry rabbits ( G2), and cholesterol feeding + abdominal artery injury + losartan treatment rabbits ( G3 ). The latter two groups were constantly fed with cholesterol diet for 6 weeks and underwent intimal denudation in the abdominal artery after a two- week cholesterol diet. G3 group was orally given losartan ( 10 mg/kg) 1 day after intimal denudation in the abdominal ar- tery. Then the arteries were prepared for histological observation. The expressions of PPAR~ and PAI-1 protein and mRNA were measured by immunohistoehemistry method and RT-PCR. Results: At the end of 6 weeks, the intimal thickness (IT), IT/media thickness(MT) ratio, intimal area (IA), IA/media area(MA) ratio among 3 groups were different( F was 48. 700,69. 100,133. 200, and 97. 500, P 〈 0. 001 ). The protein and mRNA expressions of PPARγ and PAI-1 among 3 groups were different( F was 13. 800,26. 500,9. 200, and 17. 400, P 〈 0.05 ). Oonclusion : Losartan could inhibit intireal proliferation and improve vessel remodeling after balloon injury. The mechanism of anti-atherosclerosis by losartan may be related to elevation of PPARγand the expression of PAI-1.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第2期293-296,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 氯沙坦 过氧化物酶体增殖物激活受体- 纤溶酶原激活物抑制因子-1 动脉粥样硬化 losartan peroxisome proliferators-activated receptor-γ plasminogen activator inhibitor-1 atherosclerosis rabbit
  • 相关文献

参考文献10

  • 1Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature [ J ]. Circ Res, 2008,102 ( 3 ) :283. 被引量:1
  • 2Jiang Q, Heneka M, Landreth GE. The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer' s disease: therapeutic implications [ J]. CNS Drugs, 2008,22 ( 1 ) : 1. 被引量:1
  • 3Kuusisto J, Andrulionyte L, Laakso M. Atherosclerosis and cardiovascular risk reduction with PPAR agonists[ J]. Curr Atheroscler Rep,2007,9 (4) :274. 被引量:1
  • 4Block PC, Baughman KL, Pasternak RC, et al. Transluminal angioplasty : correlation of morphologic and angiographic findings in an experimental model [J]. Circulation,1980,61 (4):778. 被引量:1
  • 5Staels B. PPAR agonists and the metabolic syndrome[J]. Therapie, 2007, 62(4):319. 被引量:1
  • 6Yu Y, Fukuda N, Yao EH, et al. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension[ J]. Am J Hypertens ,2008 ,21 ( 1 ) :72. 被引量:1
  • 7Imayama I, Iehiki T, Inanaga K, et al. Telmisartan downregulates angiotensin Ⅱ type 1 receptor through activation of peroxisome proliferator-activated receptor gamma [ J ]. Cardiovasc Res, 2006,72 ( 1 ) : 184. 被引量:1
  • 8Aleksic N, Wang YW, Ahn C, et al. Assessment of coronary heart disease risk by combined analysis of coagulation factors [ J ]. Atherosclerosis , 2008,198 (2) :29,4. 被引量:1
  • 9Brown N J, Bradford J, Wang Z, et al. Modulation of angiotensin Ⅱ and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency [J]. Kidney Int,2007,72( 1 ) :72. 被引量:1
  • 10Boyle PJ. Diabetes mellitus and macrov.ascular disease: mechanisms and mediators [ J ]. Am J Med, 2007, 120 (9 Suppl 2) :S12. 被引量:1

同被引文献4

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部